- Home
- SRZN vs SAMG Comparison
SRZN vs SAMG Comparison
Compare SRZN & SAMG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SRZN
- SAMG
- Stock Information
- Founded
- SRZN 2015
- SAMG 2002
- Country
- SRZN United States
- SAMG United States
- Employees
- SRZN N/A
- SAMG N/A
- Industry
- SRZN Medicinal Chemicals and Botanical Products
- SAMG Investment Managers
- Sector
- SRZN Health Care
- SAMG Finance
- Exchange
- SRZN Nasdaq
- SAMG Nasdaq
- Market Cap
- SRZN 117.8M
- SAMG 110.9M
- IPO Year
- SRZN N/A
- SAMG 2013
- Fundamental
- Price
- SRZN $13.23
- SAMG $13.56
- Analyst Decision
- SRZN Strong Buy
- SAMG
- Analyst Count
- SRZN 2
- SAMG 0
- Target Price
- SRZN $38.50
- SAMG N/A
- AVG Volume (30 Days)
- SRZN 92.5K
- SAMG 30.6K
- Earning Date
- SRZN 11-07-2025
- SAMG 10-30-2025
- Dividend Yield
- SRZN N/A
- SAMG 6.27%
- EPS Growth
- SRZN N/A
- SAMG N/A
- EPS
- SRZN N/A
- SAMG 0.72
- Revenue
- SRZN $3,604,000.00
- SAMG $125,322,000.00
- Revenue This Year
- SRZN N/A
- SAMG $4.23
- Revenue Next Year
- SRZN N/A
- SAMG $7.48
- P/E Ratio
- SRZN N/A
- SAMG $18.64
- Revenue Growth
- SRZN N/A
- SAMG 4.23
- 52 Week Low
- SRZN $5.90
- SAMG $13.23
- 52 Week High
- SRZN $18.17
- SAMG $19.20
- Technical
- Relative Strength Index (RSI)
- SRZN 51.18
- SAMG 35.55
- Support Level
- SRZN $12.12
- SAMG $13.23
- Resistance Level
- SRZN $14.18
- SAMG $13.79
- Average True Range (ATR)
- SRZN 0.75
- SAMG 0.38
- MACD
- SRZN 0.06
- SAMG -0.00
- Stochastic Oscillator
- SRZN 61.92
- SAMG 16.88
About SRZN Surrozen Inc.
Surrozen Inc is a clinical-stage biotechnology company committed to discovering and developing drug candidates to selectively modulate the Wnt pathway, a critical mediator of tissue repair, in a broad range of organs and tissues. Its product candidate includes SZN-1326 (Fzd5/Lrp6, SWAP), SZN-413 and SZN-043 (E3/ASGR1, SWEETS).
About SAMG Silvercrest Asset Management Group Inc.
Silvercrest Asset Management Group Inc is a wealth management firm focused on providing financial advisory and related family office services to ultra-high net-worth individuals and institutional investors. It advises clients on traditional investment strategies focused on equities, fixed income and cash as well as non-traditional investment strategies including hedge funds, private equity funds, real estate and commodities. It also provides clients with family office services and related administrative services, which include financial planning, tax planning and preparation, partnership accounting and fund administration, and consolidated wealth reporting. The company derives revenues principally from assets under management.